Skip to content
Governance Register

← US public companies

Verrica Pharmaceuticals Inc.

SEC CIK 1660334 · VRCA · last insider filing 2026-06-09

Directors (from insider filings)

NameCapacity as filedFilings
Prygocki Mark A SR Director filed 2018 - 2026
Corcoran Gavin Director filed 2025 - 2026
Nguyen Diem Director filed 2020 - 2026
Eichenfield Lawrence Director filed 2020 - 2026
Rieger Jayson Director · CEO and President filed 2024 - 2026
Frantzreb Charles Director filed 2025 - 2025
Manning Paul B Director filed 2018 - 2025
Goldenberg Gary Director · Chief Medical Officer filed 2018 - 2025
White Ted Director · President and CEO filed 2018 - 2025
Stalfort Sean Director filed 2018 - 2024
Ballaron Craig Director filed 2019 - 2024
Oclassen Glenn A Director filed 2018 - 2019

Officers (from insider filings)

NameTitle as filedFilings
Rosenberg Noah L. CMO filed 2025 - 2026
Zawitz David Chief Operating Officer filed 2024 - 2026
Kirby John J. Interim CFO filed 2024 - 2025
Hayes Christopher G. General Counsel filed 2020 - 2025
Bonaccorso Joe Chief Commercial Officer filed 2018 - 2025
Kohler Terry Chief Financial Officer filed 2021 - 2025
Davis A Brian Chief Financial Officer filed 2019 - 2021
Burnett Patrick Chief Medical Officer filed 2018 - 2020
Palczuk Linda Chief Operating Officer filed 2018 - 2019
Degnan Chris Chief Financial Officer filed 2018 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.